AmbAgon Therapeutics Inc.
ID: 7024510Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins
2
Funding Rounds
$92.2m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company AmbAgon Therapeutics Inc. has raised a total of $85m in funding over 2 rounds.
Key Insights:
- AmbAgon Therapeutics Inc. Series A round, January 2022: $85m
- AmbAgon Therapeutics Inc. funding round, July 2020: $7.2m
Industries
AmbAgon Therapeutics Inc. is active in the following industries: